Yuhan set to export Revanex to Indian market

Published: 2009-07-13 06:57:00
Updated: 2009-07-13 06:57:00
Yuhan Corporation said on July 8 that it signed a licensing agreement with India based Zydus Cadila over the export of its novel acid pump antagonist Revanex (revaprazan) into Indian market.

Under the agreement, Yuhan will supply Revanex tablets over the next 10 years with proper milestone pay...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.